Lilly doubles investment in Indiana site to enhance API manufacturing
The company is expanding its Indiana facility to increase API capacity for diabetes and obesity treatments.
Source: yahoo.com
Stay updated with breaking news from Pharmaceutical Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company is expanding its Indiana facility to increase API capacity for diabetes and obesity treatments.
The partnership is a strategic move for DRL as it aims to expand into the cardio and diabetes therapeutic areas.
Taiba will oversee the complete sales and expenditures linked to the marketing of the product.
A research team from the University of La Laguna (ULL) conducted a study to establish the chemical composition of Hass avocado from Tenerife.
IntegriMedical's N-FIS technology employs a high-velocity jet stream to administer drugs and biologics.